We found for the first time that azithromycin shifted SLE macrophages towards a M2 phenotype, characterized by decreased IL-1β, IL-6, and TNF-α, increased Arg-1, Fizz-1, IL-10, and higher phagocytic activity. The gene discussed is RETNLB; the disease is systemic lupus erythematosus.